Malaysia-based Aurelius Healthcare, which earlier made headlines for being in talks to acquire a majority stake in India’s Ivy Health and Life Sciences Pvt. Ltd, has moved out of the transaction, multiple sources privy to the development told DealStreetAsia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
